Advertisement
Skip to Content

Live Oak Health Sciences LOGSX

Medalist Rating as of | See Oak Associates Investment Hub
  • NAV / 1-Day Return 19.72  /  0.50 %
  • Total Assets 51.1 Mil
  • Adj. Expense Ratio
    1.020%
  • Expense Ratio 1.020%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Value
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 0.34%
  • Turnover 47%

Morningstar’s Analysis LOGSX

Will LOGSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Live Oak Health Sciences's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LOGSX

  • Current Portfolio Date Mar 31, 2023
  • Equity Holdings 32
  • Bond Holdings 0
  • Other Holdings 1
  • % Assets in Top 10 Holdings 38.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Prime 4.51 4/3/23

5.27
2,853,345
4.84
2,621,127
Healthcare
4.57
2,475,520
Healthcare
4.06
2,199,751
Healthcare
3.96
2,144,880
Healthcare
3.70
2,000,132
Healthcare
3.58
1,939,760
Healthcare
3.53
1,913,206
Healthcare
3.49
1,889,809
Healthcare
3.33
1,804,846
Healthcare